FCGR2A and cancer: Consequently, we believe alternative TEPs mRNAs, including RSL24D1, IFI27, CRYM, HBD, IFITM3, FCGR2A, and KLHDC8B mRNA, can potentially serve as non‐invasive biomarkers for diagnosing cancers and can even predict the prognosis of pan‐cancer.